PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-1.63%)
As of: Oct 1, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) Total Liabilities (2011 - 2026)

Updated

PharmaCyte Biotech (PMCB) posted Total Liabilities of $9.2 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), up 506.0% from $1.52 million a year earlier but down 31.6% from the prior quarter.

Analysis

PharmaCyte Biotech (PMCB) Total Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2026 (ended Apr 30, 2026), PharmaCyte Biotech's Total Liabilities came in at $13.46 million, up 310.7% from FY2025.

  • Annual Total Liabilities shows a five-year compound annual growth rate of 79.4% (FY2021 to FY2026).
  • In prior fiscal years, PharmaCyte Biotech's Total Liabilities was $3.28 million in FY2025 (-89.8%), $32.26 million in FY2024, $586,581 in FY2023 (-16.7%) and $704,370 in FY2022 (-2.8%).
  • Quarterly Total Liabilities has run from a low of $186,122 in fiscal Q2 2022 to a high of $42.11 million in fiscal Q2 2024 over five years.
  • On a year-over-year basis, Total Liabilities has increased in each of the last four quarters, with growth averaging 118.1% over the last eight quarters.
  • The strongest year-over-year quarter for Total Liabilities in the past five years was fiscal Q2 2023, with growth of 604.4%; the weakest was fiscal Q1 2026, with a decline of 93.2%.
  • According to Business Quant data, Total Liabilities for the three prior fiscal quarters was $13.46 million (Q4 2026), $17.76 million (Q3 2026) and $20.74 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 116.09 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 141.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 65.46 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 37.53 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 7.18 Bn
10 PharmaCyte Biotech 4.40 Mn 4.40 Mn - 9.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 9.20 Mn
Apr 30, 2026 13.46 Mn
Jan 31, 2026 17.76 Mn
Oct 31, 2025 20.74 Mn
Jul 31, 2025 1.52 Mn
Apr 30, 2025 3.28 Mn
Jan 31, 2025 3.58 Mn
Oct 31, 2024 11.65 Mn
Jul 31, 2024 22.49 Mn
Apr 30, 2024 32.26 Mn
Jan 31, 2024 39.98 Mn
Oct 31, 2023 42.11 Mn
Jul 31, 2023 40.69 Mn
Apr 30, 2023 586,581.00
Jan 31, 2023 827,834.00
Oct 31, 2022 1.31 Mn
Jul 31, 2022 1.09 Mn
Apr 30, 2022 704,370.00
Jan 31, 2022 612,976.00
Oct 31, 2021 186,122.00
API Access

PharmaCyte Biotech Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=PMCB&period=max&api_key=YOUR_API_KEY